NEWS & ANNOUNCEMENTS

Chairman of VIVA Foundation for Children with Cancer (VIVA), Mrs. Jennifer Yeo, will be featured on the upcoming <我董你> programme on Channel 8 TV

Chairman of VIVA Foundation for Children with Cancer (VIVA), Mrs. Jennifer Yeo, will be featured on the upcoming <我董你> programme on Channel 8 TV this Sunday 19th Jan 2025, at 9 PM! Mrs Yeo will be sharing more about VIVA. Stay tuned!

Congratulations to Prof Allen Yeoh and his team on their groundbreaking cancer treatment breakthrough!

Congratulations to Prof Allen Yeoh and his team on their groundbreaking cancer treatment breakthrough! Your dedication to fighting childhood cancer is truly inspiring. We're honoured to support innovative research such as this.

See all

VIVA Gut Microbiome and Cancer Education Webinar Series:

Gut Microbiome and Nutrition

6 Aug 2022 (Saturday) | 08:30 - 09:30 (UTC+8 | SGT) | Check your Time Zone

Programme Synopsis

The microbiome is the collection of all the microbes that live in and on the human body. These microbes include bacteria, viruses, fungi, and protozoa. The microbiome is essential for human health, as it helps to regulate the immune system, digestion, and metabolism. Nutrition plays a crucial role in maintaining a healthy microbiome. In particular, dietary fiber is essential for fostering the growth of beneficial bacteria. Conversely, processed foods and sugar can promote the growth of harmful bacteria. Disorders such as obesity, inflammatory bowel disease, and some cancers have been linked to an imbalance in the microbiome. The composition of the gut microbiome can influence disease risk factors such as inflammation and metabolism. Thus, nutrition and the gut microbiome are intimately connected and have major implications for diseases including cancers.

Watch it Again!

SPEAKER

A/Prof Sunny Wong

Associate Professor of Nutrition, Digestion and Metabolism and Assistant Dean, Academic Medicine, Lee Kong Chian School of Medicine
Associate Professor, Lee Kong Chian School of Medicine
Nanyang Technological University
Singapore

Dr Sunny Wong is a clinician-scientist and an Associate Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. He received his MBChB with Honors at the Chinese University of Hong Kong, and his DPhil in University of Oxford on human genetics and infectious diseases. He completed his clinical training in gastroenterology and endoscopy in the Prince of Wales Hospital Hong Kong. His main research interest is on gut microbiome, investigating the host-microbe interaction in digestive and metabolic diseases, and exploring this for discovery of novel biomarkers and therapeutics. He has won several awards, including the Asia Pacific Digestive Week Emerging Leaders Lectureship (2021), the Sir David Todd Lectureship (2020), the Lo Ying Shek Chi Wai Foundation Meritorious Research Award (2020), and the Croucher Foundation Award (2014). He has published over 160 peer-reviewed articles including papers in Nature Genetics, Nature Communications, Gastroenterology and Gut. He is currently an Associate Editor for the Journal of Gastroenterology and Hepatology.

VIVA Gut Microbiome and Cancer Education Webinar Series:

Gut Microbiome and Cancer Recovery

5 Nov 2022 (Saturday) | 08:30 - 09:30 (UTC+8 | SGT) | Check your Time Zone

Programme Synopsis

The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint inhibitors (ICIs), whereas supplementation of distinct bacterial species restores responses to the anticancer drugs. Accumulating evidence has revealed the potential of modulating the gut microbiota to enhance the efficacy of anticancer drugs. Regardless of the valuable findings by preclinical models and clinical data of patients with cancer, a more thorough understanding of the interactions of the microbiota with cancer therapy helps researchers identify novel strategy for more effective treatment and reduce treatment complication. We will discuss the scientific evidence on the role of gut microbiota in cancer treatment, and highlight the latest knowledge and technologies leveraged to target specific bacteria that contribute to tumourigenesis. We will also discuss the limitations of current microbiome research in the context of cancer treatment and ongoing efforts to overcome these challenges.

WATCH IT AGAIN!

SPEAKER

A/Prof Joanne Ngeow

BMedSci, MBBS, FRCP, MPH, FAMS
Assoc Prof, Lee Kong Chian School of Medicine
Nanyang Technological University, Singapore
Senior Consultant, Division of Medical Oncology
National Cancer Centre Singapore

Dr Joanne Ngeow, BMedSci, MBBS, FRCP, MPH is Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore and Associate Professor (Genomic Medicine) at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic clinical interest in hereditary cancer syndromes and translational clinical cancer genetics. Dr Ngeow is funded by the National Medical Research Council Clinician Scientist Award and Ministry of Health to explore how gene-environmental interactions predisposes to cancer initiation and progression and the implementation of genomics into routine clinical care. Dr Ngeow is one of the Principal Investigators of the Health for Life in Singapore Study (HELIOS), a state-of-the-art multi-ethnic population cohort study.

MODERATOR:

A/Prof Sunny Wong

Associate Professor of Nutrition, Digestion and Metabolism and Assistant Dean, Academic Medicine, Lee Kong Chian School of Medicine
Associate Professor, Lee Kong Chian School of Medicine
Nanyang Technological University
Singapore